Search - tctmd.com

Displaying 841 - 860 of 2435

Sort: Relevancy | Date

Presentation TCT 2017

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Presenter: Subhash Banerjee, Robert A. Lookstein

October 30, 2017

Presentation TCT 2017

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso

October 30, 2017

Presentation TCT 2017

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Presenter: Subhash Banerjee, Bryan T. Fisher

October 30, 2017

Presentation TCT 2017

Is There a Role for Sidebranch Treatment With Drug-Eluting Balloons?

Presenter: Antonio Colombo, Manuel Pan, Jozica Sikic

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller

October 30, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito

October 30, 2017

Presentation TCT 2017

Drug Coated Balloons in Complex SFA Lesions: Case Examples and Data

Presenter: Subhash Banerjee

October 30, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

Presenter: Ioannis Iakovou, Gert Richardt, Christophe Dubois

October 30, 2017

Presentation TCT 2017

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

Presenter: Ioannis Iakovou, Gert Richardt, Clemens von Birgelen

October 30, 2017

Presentation TCT 2017

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter

October 30, 2017

Presentation TCT 2017

Will Atherectomy Improve the Results of Drug Coated Balloons? Preclinical and Early Clinical Data

Presenter: Lawrence A. Garcia, Mehdi H. Shishehbor

October 30, 2017

Presentation TCT 2017

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes

October 30, 2017

Presentation TCT 2017

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Presenter: Ioannis Iakovou, Gert Richardt, Renu Virmani

October 30, 2017

Presentation TCT 2017

Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)!

Presenter: Giulio G. Stefanini, Stephan Windecker, Philip M. Urban

October 30, 2017

Presentation TCT 2017

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Presenter: Giulio G. Stefanini, Stephan Windecker, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Presenter: Giulio G. Stefanini, Stephan Windecker, Stefan K. James

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Elvin Kedhi

October 30, 2017

Presentation TCT 2017

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari

October 30, 2017

Presentation TCT 2017

POT vs Kissing Balloon Inflations: Alternatives or Complementary?

Presenter: Terje K. Steigen, Leif Thuesen, Bernard R. Chevalier

October 30, 2017

Advertisement

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Is There a Role for Sidebranch Treatment With Drug-Eluting Balloons?

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Drug Coated Balloons in Complex SFA Lesions: Case Examples and Data

PLLA-Based Biolimus A9 Elution I: Outcomes With the BioMatrix Family of DES

The Orsiro Sirolimus-eluting Stent: Outcomes From the BIOFLOW and BIORESORT Trials

MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique?

Will Atherectomy Improve the Results of Drug Coated Balloons? Preclinical and Early Clinical Data

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Pros and Cons of Bioabsorbable Polymer-Based DES: Will They Translate Into Improved Clinical Outcomes Compared to the Best Durable Polymer-Based DES?

Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)!

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

BioNIR: Specifications and BIONICS/NIREUS Results in Perspective

POT vs Kissing Balloon Inflations: Alternatives or Complementary?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content